New study identifies lncRNAs CBR3-AS1 and PCA3 as potential biomarkers for early detection of gastric cancer
“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively”
2025-06-05
(Press-News.org)
“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively.”
BUFFALO, NY- June 5, 2025 – A new research paper was published in Volume 16 of Genes & Cancer on May 9, 2025, titled “Evaluation of LncRNAs CBR3-AS1 and PCA3 expression in Gastric cancer and their correlation to clinicopathological variables.”
Researchers, led by first author Parisa Najari and corresponding author Reza Safaralizadeh from the University of Tabriz, investigated how two long non-coding RNAs (lncRNAs), CBR3-AS1 and PCA3, are expressed in gastric cancer (GC) tissues compared to nearby healthy tissues. They found that both lncRNAs were significantly overexpressed in tumor samples, suggesting their involvement in GC development. The findings support future use of these molecules as diagnostic biomarkers.
Gastric cancer remains one of the leading causes of cancer-related deaths worldwide, largely due to its late detection. Reliable early detection tools are critical to improving survival rates. To explore potential biomarkers, the researchers analyzed GC tumor and adjacent normal tissue samples from 100 patients. Both CBR3-AS1 and PCA3 showed consistently higher expression in cancerous tissues, indicating a possible role in tumor progression or as markers of disease.
The study also examined whether expression of these lncRNAs correlated with clinical features such as patient age, tumor size, cancer stage, or Helicobacter pylori infection. No statistically significant associations were found. However, the clear difference in expression between tumor and normal tissues supports their potential diagnostic value.
To assess this hypothesis further, the team conducted receiver operating characteristic (ROC) curve analysis. The results showed that CBR3-AS1, in particular, could serve as a reasonably accurate biomarker for distinguishing GC tissues.
“The ROC curve’s findings lead to the conclusion that the genes lncRNAs PCA3 and CBR3-AS1, with AUC values of 0.68 and 0.79, respectively, suggest that they could play carcinogenic roles in GC and may act as moderate diagnostic biomarkers for GC.”
LncRNAs are RNA molecules that do not code for proteins but help regulate gene activity. Because of their stability and regulatory functions, they are gaining attention as tools for cancer diagnosis and treatment. CBR3-AS1 has been linked to tumor growth and drug resistance in other cancers, while PCA3 is already FDA-approved as a diagnostic marker for prostate cancer, further supporting its relevance.
While the results are promising, the authors note that the study was conducted at a single center and did not explore how these molecules influence cancer progression. Larger, multi-center studies and additional validation will be essential to confirm their clinical utility.
In summary, CBR3-AS1 and PCA3 emerge as promising molecular markers for GC. With further validation, these lncRNAs could support earlier diagnosis and help advance more personalized and effective treatment strategies.
Continue reading: DOI: https://doi.org/10.18632/genesandcancer.241
Correspondence to: Reza Safaralizadeh – safaralizadeh@tabrizu.ac.ir
Keywords: cancer, gastric cancer, LncRNAs, CBR3-AS1, PCA3, qRT-PCR
Click here to sign up for free Altmetric alerts about this article.
About Genes & Cancer:
Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, Genes & Cancer also aims to attract papers in the areas of genomics, drug development and systems biology.
To learn more about Genes & Cancer, visit www.genesandcancer.com and connect with us on social media:
X
Facebook
YouTube
LinkedIn
Instagram
For media inquiries, please contact media@impactjournals.com.
Genes & Cancer Journal Office
6666 East Quaker St., Suite 1
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 3)
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-06-05
About The Study: Health care employment growth decreased amid the pandemic but fully recovered by 2024. This recovery contrasts with non–health care employment trends and may result from health care financing via insurance coverage shielding health care employment from macroeconomic fluctuations.
Corresponding Author: To contact the corresponding author, Thuy Nguyen, PhD, email thuydn@umich.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.8588)
Editor’s Note: Please see the article for additional information, including ...
2025-06-05
About The Article: This Viewpoint, by Vinay Prasad, MD, MPH, of the Center for Biologics Evaluation and Research, Food and Drug Administration, and colleagues discusses a safety communication recommending a pause in the use of live attenuated chikungunya virus vaccine.
Corresponding Author: To contact the corresponding author, Vinay Prasad, MD, MPH, email vinayak.prasad@fda.gov.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.9393)
Editor’s ...
2025-06-05
Around midday, Earth’s ionosphere sometimes experiences sharp, short-lived dips in its electron density—an unusual phenomenon known as a noontime bite-out. A new study takes a global view of these midday disruptions, using finely detailed ionospheric maps to compare their behavior in years of high and low solar activity. The research reveals that noontime bite-outs are more widespread and frequent during solar minimum, especially in winter and at higher latitudes. With detailed tracking of timing, intensity, and ...
2025-06-05
As the largest MS organization in the world and a global leader of the MS movement, the National Multiple Sclerosis Society is committed to supporting research and career development that will accelerate breakthroughs in understanding, treating, and ultimately curing MS. The Society is pleased to highlight a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities.
Awards are summarized below along with individual links to learn more about the details of each award, eligibility, and application instructions.
The National MS Society is offering funding opportunities that invest ...
2025-06-05
Designed a high-performance double-spoke superconducting cavity.
The research team implemented comprehensive electromagnetic and mechanical optimizations on the double-spoke superconducting cavity, achieving three key improvements: reduction of peak electric field during normal operation, suppression of multipacting effects, and enhanced manufacturability. A dedicated Buffered Chemical Polishing tooling system was developed for double-spoke superconducting cavities with complex structures, ensuring uniform acid etching and achieving high Q-values (Q > 3.4×10¹⁰ @ Eₐcc = 9 MV/m).
Developed a high-performance cryomodule
The ...
2025-06-05
The accumulation of microplastics in the environment, and within our bodies, is an increasingly worrisome issue. But predicting where these ubiquitous particles will accumulate, and therefore where remediation efforts should be focused, has been difficult because of the many factors that contribute to their dispersal and deposition.
New research from MIT shows that one key factor in determining where microparticles are likely to build up has to do with the presence of biofilms. These thin, sticky biopolymer layers are shed by microorganisms and can accumulate ...
2025-06-05
Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in patients whose positive axillary nodes at presentation convert to negative following neoadjuvant chemotherapy. These results were recently published in the New England Journal of Medicine.
The study enrolled 1,641 patients stratified by type of surgery (mastectomy, lumpectomy), hormone receptor status (ER-positive and/or PgR-positive; ER- and PgR-negative), HER2 status, adjuvant chemotherapy use, and pathologic complete response (pCR) in the breast, then randomized to RNI vs. ...
2025-06-05
Recent advances have resulted in highly effective “tissue-agnostic” drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children. In an opinion paper publishing June 5 in the Cell Press journal Trends in Cancer, oncologists call for “ag(e)nostic” cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages.
“Cancer treatment in children is a huge unmet need. These drugs are extremely effective, and we want to see children have access to them,” says senior author Razelle ...
2025-06-05
Genetic ancestry is much more complicated than how people report their race and ethnicity. New research, using data from the National Institutes of Health’s (NIH) All of Us Research Program, finds that people who identify as being from the same race or ethnic group can have a wide range of genetic differences. The findings are reported June 5 in the Cell Press journal the American Journal of Human Genetics.
As doctors and researchers learn more about how genetic variants influence the incidence and course of human diseases, the study of genetic ancestry has become increasingly important. This research is driving the field of precision medicine, ...
2025-06-05
Nematodes are the most abundant animal on earth, but when times get tough, these tiny worms have a hard time moving up and out. So, they play to the strength of their clade. If food runs out and competition turns fierce, they slither towards their numerous kin. They climb onto each other and over one another until their bodies forge a living tower that twists skyward where they might hitch a ride on a passing animal to greener and roomier pastures.
At least that’s what scientists assumed. For decades, these worm structures ...
LAST 30 PRESS RELEASES:
[Press-News.org] New study identifies lncRNAs CBR3-AS1 and PCA3 as potential biomarkers for early detection of gastric cancer
“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively”
